Adjuvant Use of Abciximab for Balloon Angioplasty of Symptomatic Middle Cerebral Artery Stenosis

References

• Bhatt D. L., Topol E. J. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. J Am Med Assoc 2000; 284: 1549–58
   PubMed Web of Science ®Google Scholar
• Clark W. M., Barnwell S. L., Nesbit G., O'Neill O. R., Wynn M. L., Coull B. M. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995; 26: 1200–4
   PubMed Web of Science ®Google Scholar
• Dangas G., Fuster V. Management of restenosis after coronary intervention. Am Heart J 1996; 132: 428–36
   PubMed Web of Science ®Google Scholar
• EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994; 330: 956–61
   PubMed Web of Science ®Google Scholar
• Kim J. K., Ahn J. Y., Lee B. H., Chung Y. S., Chung S. S., Kim O. J., et al. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short-term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 2004; 75: 847–51
   PubMed Web of Science ®Google Scholar
• Lee D. H., Ahn J. H., Jeong S. S., Eo K. S., Park M. S. Routine transradial access for conventional cerebral angiography: a single operator's experience of its feasibility and safety. Br J Radiol 2004; 77: 831–8
   PubMed Web of Science ®Google Scholar
• Lee J. H., Kwon S. U., Suh D. C., Kim J. S. Percutaneous transluminal angioplasty for symptomatic middle cerebral artery stenosis: long-term follow-up. Cerebrovasc Dis 2003; 15: 90–7
   PubMed Web of Science ®Google Scholar
• Mori T., Fukuoka M., Kazita K., Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. Am J Neuroradiol 1998; 19: 1525–33
   PubMed Web of Science ®Google Scholar
• Mori T., Mori K., Fukuoka M., Arisawa M., Honda S. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology 1997; 39: 111–16
   PubMed Web of Science ®Google Scholar
• Mori T., Mori K., Fukuoka M., Honda S. Percutaneous transluminal angioplasty for total occlusion of middle cerebral arteries. Neuroradiology 1997; 39: 71–4
   PubMed Web of Science ®Google Scholar
• Nelken N., Schneider P. A. Advances in stent technology and drug-eluting stents. Surg Clin North Am 2004; 84: 1203–36
   PubMed Web of Science ®Google Scholar
• Purdy P. D., Devous M. D., Sr., Unwin D. H., Giller C. A., Batjer H. H. Angioplasty of an atherosclerotic middle cerebral artery associated with improvement in regional cerebral blood flow. Am J Neuroradiol 1990; 11: 878–80
   PubMed Web of Science ®Google Scholar
• Qureshi A. I., Suri M. F., Ali Z., Kim S. H., Lanzino G., Fessler R. D., et al. Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery 2002; 50: 466–73
   PubMed Web of Science ®Google Scholar
• RESTORE Investigators. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation 1997; 96: 1445–53
   PubMed Web of Science ®Google Scholar
• Song J. K., Niimi Y., Fernandez P. M., Brisman J. L., Buciuc R., Kupersmith M. J., et al. Thrombus formation during intracranial aneurysm coil placement: treatment with intra-arterial abciximab. Am J Neuroradiol 2004; 25: 1147–53
   PubMed Web of Science ®Google Scholar
• Suh D. C., Sung K. B., Cho Y. S., Choi C. G., Lee H. K., Lee J. H., et al. Transluminal angioplasty for middle cerebral artery stenosis in patients with acute ischemic stroke. Am J Neuroradiol 1999; 20: 553–8
   PubMed Web of Science ®Google Scholar
• Toucho H. Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation. J Neurosurg 1995; 82: 953–60
   PubMed Web of Science ®Google Scholar
• Wholey M. H., Eles G., Toursakissian B., Bailey S., Jarmolowski C., Tan W. A. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther 2003; 10: 33–41
   PubMed Web of Science ®Google Scholar
• Yokote H., Terada T., Ryujin K., Konoshita Y., Tsuura M., Nakai E., et al. Percutaneous transluminal angioplasty for intracranial arteriosclerotic lesions. Neuroradiology 1998; 40: 590–6
   PubMed Web of Science ®Google Scholar